UNSPSC 51281630: Astromicin

This classification denotes an aminoglycoside antibiotic with the molecular formula C17H35N5O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7JHD84H15J, chemically known as 2-amino-N-[(1S,2R,3R,4S,5S,6R)-4-amino-3-[(2R,3R,6S)-3-amino-6-(1-aminoethyl)tetrahydropyran-2-yl]oxy-2,5-dihydroxy-6-methoxy-cyclohexyl]-N-methyl-acetamide but generally known as astromicin, which bears US NIH Compound Identifier 65345.

UNSPSC 51281630 Astromicin is a Commodity code that in practice does not map to the pharmaceutical products and public-health supplies state and local governments are currently soliciting. The recent opportunities tagged under this code — a piggyback pharmaceutical warehouse contract from the Illinois Department of Public Health for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and drug deactivation systems — involve antibiotic and opioid-reversal agents, none of which are astromicin-specific. The code appears to be a mislabeling or overly broad categorization rather than a meaningful signal of actual demand for the Commodity as named.

No open solicitations tagged to UNSPSC 51281630 are currently live. The Illinois Department of Public Health awarded a completed contract to Chartwell Rx LLC on August 28, 2026, for pharmaceutical supply through the MMCAP Infuse cooperative purchasing vehicle with a total award of $2,999,999.11 over three years. The Seminole County opportunity, posted June 30, 2026, with a July 26, 2023 response deadline, has already closed. Neither opportunity reflects active procurement under this code code as of October 2026. Business development professionals should monitor whether state purchasing offices recategorize pharmaceutical and public-health supply solicitations under codes more specifically aligned with the products being bought, as the current tagging offers little actionable signal.